5 studies found for:    davunetide
Show Display Options
Rank Status Study
1 Completed A Multicenter Study of NAP (AL-108) in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: AL-108;   Drug: Placebo
2 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray
3 Completed Study to Evaluate Safety, Tolerability, and Effect of AL208 on Mild Cognitive Impairment Following Coronary Artery Bypass Graft Surgery
Condition: Mild Cognitive Impairment
Interventions: Drug: AL-208;   Drug: Placebo
4 Completed Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Interventions: Drug: Davunetide;   Drug: Placebo
5 Completed Safety, Tolerability and Efficacy Study to Evaluate Subjects With Mild Cognitive Impairment
Condition: Mild Cognitive Impairment, So Stated
Interventions: Drug: AL-108;   Drug: Placebo

Indicates status has not been verified in more than two years